Cargando…
Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization
PURPOSE: Skeletal muscle index (SMI) is a promising predictor of clinical outcomes in patients with malignant diseases. As a simpler surrogate of sarcopenia-psoas muscle index (PMI), its predict value for overall survival (OS) after transarterial chemoembolization (TACE) for hepatocellular carcinoma...
Autores principales: | Zhang, Jin-Xing, Yan, Hai-Tao, Ding, Ye, Liu, Jin, Liu, Sheng, Zu, Qing-Quan, Shi, Hai-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176702/ https://www.ncbi.nlm.nih.gov/pubmed/35639492 http://dx.doi.org/10.1080/07853890.2022.2081872 |
Ejemplares similares
-
Identification of an eight-gene signature for survival prediction for patients with hepatocellular carcinoma based on integrated bioinformatics analysis
por: Qiao, Guo-jie, et al.
Publicado: (2019) -
Post-transarterial Chemoembolization Tumor Rupture in a Patient with Autoimmune Hepatitis Cirrhosis and Hepatocellular Carcinoma
por: Gala, Khushboo, et al.
Publicado: (2020) -
Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Kong, Fei, et al.
Publicado: (2020) -
Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
por: Lu, Lingling, et al.
Publicado: (2021) -
Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis
por: Yu, Xue-Chen, et al.
Publicado: (2022)